Report
Research Department
EUR 100.00 For Business Accounts Only

IBERIAN DAILY 26 FEBRUARY (ANÁLISIS BANCO SABADELL)

IBERIAN DAILY 26 FEBRUARY (ANÁLISIS BANCO SABADELL)
Underlyings
Baron de Ley S.A.

Baron de Ley is engaged in the growing, production, maturing, bottling and marketing of Rioja wines. Co. is also engaged in the processing of alcoholic and soft drink beverages in general. Co. produces a variety of wines under the following brand names: Baron de Ley®, Finca Monasterio®, Club Privado®, Coto de Imaz®, Coto Vintage®, El Coto®, Coto Real®, Casa Mayor®, Vina de Canonigo®, Privado®, Museum Real®, Museum®, El Meson® , Maximo®, and Jabato®.

Ferrovial S.A.

Ferrovial is a transportation company based in Spain. Co. is engaged in operations in the transportation sector. Co. specializes in the design, construction, management, administration and maintenance of transport infrastructures. Co.'s services range also includes the maintenance of parking lots, and land-, sea- and air-based transport networks. Co. is also engaged in the promotion and operation of short-stay parking lots, parking regulation and management services and promotion and sale of residents' parking.

Grupo Prisa (PRS SM)

NH Hotel Group SA

NH Hotel is engaged in the operation and management of hotels throughout Spain, the Benelux countries, Germany, and South America.

Sanofi

Sanofi is an integrated, global healthcare company focused on patient needs and engaged in the research, development, manufacture and marketing of healthcare products. Two segments make up Co.'s business: Pharmaceuticals and Vaccines. The Pharmaceuticals segment covers research, development, production and marketing of medicines, consisting of flagship products, plus a broad range of prescription medicines, generic medicines, and consumer health products. The Vaccines segment includes research, development, production and marketing of vaccines in five areas: pediatric vaccines, influenza vaccines, adult and adolescent booster vaccines, meningitis vaccines, and travel and endemic vaccines.

Provider
Sabadell
Sabadell

Analysts
Research Department

Other Reports on these Companies
Other Reports from Sabadell

ResearchPool Subscriptions

Get the most out of your insights

Get in touch